Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The uracil-DNA glycosylase pseudogene is a segment of DNA located in the human genome that shares high sequence similarity with the functional uracil-DNA glycosylase gene but has accumulated mutations and does not code for a functional protein. It is one of several non-functional copies ("pseudogenes") homologous to the uracil-DNA glycosylase gene, and it cannot participate in excision repair or base-excision DNA repair, unlike the active enzyme. Pseudogenes such as this are generally remnants of evolutionarily duplicated genes that have lost their protein-coding ability. There is no evidence of this pseudogene being a therapeutic target, relevant biomarker, or druggable entity. This information reflects the status and understanding of pseudogenes such as LOC100130177/ENSG00000254047. If you are seeking therapeutic targets, their functional counterparts (e.g., the actual uracil-DNA glycosylase enzyme, "UNG") should be considered instead.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Uracil-DNA glycosylase pseudogene.